Global Roflumilast Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
Novel COPD treatment drugs
The global market for Roflumilast is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Roflumilast market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Roflumilast market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Roflumilast market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Roflumilast market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Roflumilast players cover Alkem Laboratories, Astra Zeneca, Beltapharm Spa, Breckenridge Pharma and Hetero Drugs, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Roflumilast market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Roflumilast market, with both quantitative and qualitative data, to help readers understand how the Roflumilast market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Box.
Market Segmentation:
The study segments the Roflumilast market and forecasts the market size by Dosage Strength (250Mcg and 500Mcg,), by Application (Hospital, Clinic and Other,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by dosage strength
Chapter 1: Scope of Roflumilast, Research Methodology, etc.
Chapter 2: Executive Summary, global Roflumilast market size (sales and revenue) and CAGR, Roflumilast market size by region, by dosage strength, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Roflumilast sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Roflumilast sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by dosage strength, and dosage strength.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Roflumilast market size forecast by region, by country, by dosage strength, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Alkem Laboratories, Astra Zeneca, Beltapharm Spa, Breckenridge Pharma, Hetero Drugs, KMS Health Center, Micro Labs, MS Pharma and MSN Laboratories, etc.
Chapter 14: Research Findings and Conclusion
Novel COPD treatment drugs
The global market for Roflumilast is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Roflumilast market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Roflumilast market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Roflumilast market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Roflumilast market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Roflumilast players cover Alkem Laboratories, Astra Zeneca, Beltapharm Spa, Breckenridge Pharma and Hetero Drugs, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Roflumilast market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Roflumilast market, with both quantitative and qualitative data, to help readers understand how the Roflumilast market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Box.
Market Segmentation:
The study segments the Roflumilast market and forecasts the market size by Dosage Strength (250Mcg and 500Mcg,), by Application (Hospital, Clinic and Other,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by dosage strength
- 250Mcg
- 500Mcg
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Alkem Laboratories
- Astra Zeneca
- Beltapharm Spa
- Breckenridge Pharma
- Hetero Drugs
- KMS Health Center
- Micro Labs
- MS Pharma
- MSN Laboratories
- Viatris
- Orchid Pharma
- Orifarm Group
- Precise Group
- Takeda Pharmaceutical
- Torrent Group
Chapter 1: Scope of Roflumilast, Research Methodology, etc.
Chapter 2: Executive Summary, global Roflumilast market size (sales and revenue) and CAGR, Roflumilast market size by region, by dosage strength, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Roflumilast sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Roflumilast sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by dosage strength, and dosage strength.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Roflumilast market size forecast by region, by country, by dosage strength, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Alkem Laboratories, Astra Zeneca, Beltapharm Spa, Breckenridge Pharma, Hetero Drugs, KMS Health Center, Micro Labs, MS Pharma and MSN Laboratories, etc.
Chapter 14: Research Findings and Conclusion
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Roflumilast Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Roflumilast by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Roflumilast by Country/Region, 2017, 2022 & 2028
2.2 Roflumilast Segment by Dosage Strength
2.2.1 250Mcg
2.2.2 500Mcg
2.3 Roflumilast Sales by Dosage Strength
2.3.1 Global Roflumilast Sales Market Share by Dosage Strength (2017-2022)
2.3.2 Global Roflumilast Revenue and Market Share by Dosage Strength (2017-2022)
2.3.3 Global Roflumilast Sale Price by Dosage Strength (2017-2022)
2.4 Roflumilast Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Roflumilast Sales by Application
2.5.1 Global Roflumilast Sale Market Share by Application (2017-2022)
2.5.2 Global Roflumilast Revenue and Market Share by Application (2017-2022)
2.5.3 Global Roflumilast Sale Price by Application (2017-2022)
3 GLOBAL ROFLUMILAST BY COMPANY
3.1 Global Roflumilast Breakdown Data by Company
3.1.1 Global Roflumilast Annual Sales by Company (2020-2022)
3.1.2 Global Roflumilast Sales Market Share by Company (2020-2022)
3.2 Global Roflumilast Annual Revenue by Company (2020-2022)
3.2.1 Global Roflumilast Revenue by Company (2020-2022)
3.2.2 Global Roflumilast Revenue Market Share by Company (2020-2022)
3.3 Global Roflumilast Sale Price by Company
3.4 Key Manufacturers Roflumilast Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Roflumilast Product Location Distribution
3.4.2 Players Roflumilast Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ROFLUMILAST BY GEOGRAPHIC REGION
4.1 World Historic Roflumilast Market Size by Geographic Region (2017-2022)
4.1.1 Global Roflumilast Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Roflumilast Annual Revenue by Geographic Region
4.2 World Historic Roflumilast Market Size by Country/Region (2017-2022)
4.2.1 Global Roflumilast Annual Sales by Country/Region (2017-2022)
4.2.2 Global Roflumilast Annual Revenue by Country/Region
4.3 Americas Roflumilast Sales Growth
4.4 APAC Roflumilast Sales Growth
4.5 Europe Roflumilast Sales Growth
4.6 Middle East & Africa Roflumilast Sales Growth
5 AMERICAS
5.1 Americas Roflumilast Sales by Country
5.1.1 Americas Roflumilast Sales by Country (2017-2022)
5.1.2 Americas Roflumilast Revenue by Country (2017-2022)
5.2 Americas Roflumilast Sales by Dosage Strength
5.3 Americas Roflumilast Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Roflumilast Sales by Region
6.1.1 APAC Roflumilast Sales by Region (2017-2022)
6.1.2 APAC Roflumilast Revenue by Region (2017-2022)
6.2 APAC Roflumilast Sales by Dosage Strength
6.3 APAC Roflumilast Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Roflumilast by Country
7.1.1 Europe Roflumilast Sales by Country (2017-2022)
7.1.2 Europe Roflumilast Revenue by Country (2017-2022)
7.2 Europe Roflumilast Sales by Dosage Strength
7.3 Europe Roflumilast Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Roflumilast by Country
8.1.1 Middle East & Africa Roflumilast Sales by Country (2017-2022)
8.1.2 Middle East & Africa Roflumilast Revenue by Country (2017-2022)
8.2 Middle East & Africa Roflumilast Sales by Dosage Strength
8.3 Middle East & Africa Roflumilast Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Roflumilast
10.3 Manufacturing Process Analysis of Roflumilast
10.4 Industry Chain Structure of Roflumilast
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Roflumilast Distributors
11.3 Roflumilast Customer
12 WORLD FORECAST REVIEW FOR ROFLUMILAST BY GEOGRAPHIC REGION
12.1 Global Roflumilast Market Size Forecast by Region
12.1.1 Global Roflumilast Forecast by Region (2023-2028)
12.1.2 Global Roflumilast Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Roflumilast Forecast by Dosage Strength
12.7 Global Roflumilast Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Alkem Laboratories
13.1.1 Alkem Laboratories Company Information
13.1.2 Alkem Laboratories Roflumilast Product Offered
13.1.3 Alkem Laboratories Roflumilast Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Alkem Laboratories Main Business Overview
13.1.5 Alkem Laboratories Latest Developments
13.2 Astra Zeneca
13.2.1 Astra Zeneca Company Information
13.2.2 Astra Zeneca Roflumilast Product Offered
13.2.3 Astra Zeneca Roflumilast Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Astra Zeneca Main Business Overview
13.2.5 Astra Zeneca Latest Developments
13.3 Beltapharm Spa
13.3.1 Beltapharm Spa Company Information
13.3.2 Beltapharm Spa Roflumilast Product Offered
13.3.3 Beltapharm Spa Roflumilast Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Beltapharm Spa Main Business Overview
13.3.5 Beltapharm Spa Latest Developments
13.4 Breckenridge Pharma
13.4.1 Breckenridge Pharma Company Information
13.4.2 Breckenridge Pharma Roflumilast Product Offered
13.4.3 Breckenridge Pharma Roflumilast Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Breckenridge Pharma Main Business Overview
13.4.5 Breckenridge Pharma Latest Developments
13.5 Hetero Drugs
13.5.1 Hetero Drugs Company Information
13.5.2 Hetero Drugs Roflumilast Product Offered
13.5.3 Hetero Drugs Roflumilast Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Hetero Drugs Main Business Overview
13.5.5 Hetero Drugs Latest Developments
13.6 KMS Health Center
13.6.1 KMS Health Center Company Information
13.6.2 KMS Health Center Roflumilast Product Offered
13.6.3 KMS Health Center Roflumilast Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 KMS Health Center Main Business Overview
13.6.5 KMS Health Center Latest Developments
13.7 Micro Labs
13.7.1 Micro Labs Company Information
13.7.2 Micro Labs Roflumilast Product Offered
13.7.3 Micro Labs Roflumilast Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Micro Labs Main Business Overview
13.7.5 Micro Labs Latest Developments
13.8 MS Pharma
13.8.1 MS Pharma Company Information
13.8.2 MS Pharma Roflumilast Product Offered
13.8.3 MS Pharma Roflumilast Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 MS Pharma Main Business Overview
13.8.5 MS Pharma Latest Developments
13.9 MSN Laboratories
13.9.1 MSN Laboratories Company Information
13.9.2 MSN Laboratories Roflumilast Product Offered
13.9.3 MSN Laboratories Roflumilast Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 MSN Laboratories Main Business Overview
13.9.5 MSN Laboratories Latest Developments
13.10 Viatris
13.10.1 Viatris Company Information
13.10.2 Viatris Roflumilast Product Offered
13.10.3 Viatris Roflumilast Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Viatris Main Business Overview
13.10.5 Viatris Latest Developments
13.11 Orchid Pharma
13.11.1 Orchid Pharma Company Information
13.11.2 Orchid Pharma Roflumilast Product Offered
13.11.3 Orchid Pharma Roflumilast Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Orchid Pharma Main Business Overview
13.11.5 Orchid Pharma Latest Developments
13.12 Orifarm Group
13.12.1 Orifarm Group Company Information
13.12.2 Orifarm Group Roflumilast Product Offered
13.12.3 Orifarm Group Roflumilast Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Orifarm Group Main Business Overview
13.12.5 Orifarm Group Latest Developments
13.13 Precise Group
13.13.1 Precise Group Company Information
13.13.2 Precise Group Roflumilast Product Offered
13.13.3 Precise Group Roflumilast Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Precise Group Main Business Overview
13.13.5 Precise Group Latest Developments
13.14 Takeda Pharmaceutical
13.14.1 Takeda Pharmaceutical Company Information
13.14.2 Takeda Pharmaceutical Roflumilast Product Offered
13.14.3 Takeda Pharmaceutical Roflumilast Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Takeda Pharmaceutical Main Business Overview
13.14.5 Takeda Pharmaceutical Latest Developments
13.15 Torrent Group
13.15.1 Torrent Group Company Information
13.15.2 Torrent Group Roflumilast Product Offered
13.15.3 Torrent Group Roflumilast Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Torrent Group Main Business Overview
13.15.5 Torrent Group Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Roflumilast Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Roflumilast by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Roflumilast by Country/Region, 2017, 2022 & 2028
2.2 Roflumilast Segment by Dosage Strength
2.2.1 250Mcg
2.2.2 500Mcg
2.3 Roflumilast Sales by Dosage Strength
2.3.1 Global Roflumilast Sales Market Share by Dosage Strength (2017-2022)
2.3.2 Global Roflumilast Revenue and Market Share by Dosage Strength (2017-2022)
2.3.3 Global Roflumilast Sale Price by Dosage Strength (2017-2022)
2.4 Roflumilast Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Roflumilast Sales by Application
2.5.1 Global Roflumilast Sale Market Share by Application (2017-2022)
2.5.2 Global Roflumilast Revenue and Market Share by Application (2017-2022)
2.5.3 Global Roflumilast Sale Price by Application (2017-2022)
3 GLOBAL ROFLUMILAST BY COMPANY
3.1 Global Roflumilast Breakdown Data by Company
3.1.1 Global Roflumilast Annual Sales by Company (2020-2022)
3.1.2 Global Roflumilast Sales Market Share by Company (2020-2022)
3.2 Global Roflumilast Annual Revenue by Company (2020-2022)
3.2.1 Global Roflumilast Revenue by Company (2020-2022)
3.2.2 Global Roflumilast Revenue Market Share by Company (2020-2022)
3.3 Global Roflumilast Sale Price by Company
3.4 Key Manufacturers Roflumilast Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Roflumilast Product Location Distribution
3.4.2 Players Roflumilast Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ROFLUMILAST BY GEOGRAPHIC REGION
4.1 World Historic Roflumilast Market Size by Geographic Region (2017-2022)
4.1.1 Global Roflumilast Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Roflumilast Annual Revenue by Geographic Region
4.2 World Historic Roflumilast Market Size by Country/Region (2017-2022)
4.2.1 Global Roflumilast Annual Sales by Country/Region (2017-2022)
4.2.2 Global Roflumilast Annual Revenue by Country/Region
4.3 Americas Roflumilast Sales Growth
4.4 APAC Roflumilast Sales Growth
4.5 Europe Roflumilast Sales Growth
4.6 Middle East & Africa Roflumilast Sales Growth
5 AMERICAS
5.1 Americas Roflumilast Sales by Country
5.1.1 Americas Roflumilast Sales by Country (2017-2022)
5.1.2 Americas Roflumilast Revenue by Country (2017-2022)
5.2 Americas Roflumilast Sales by Dosage Strength
5.3 Americas Roflumilast Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Roflumilast Sales by Region
6.1.1 APAC Roflumilast Sales by Region (2017-2022)
6.1.2 APAC Roflumilast Revenue by Region (2017-2022)
6.2 APAC Roflumilast Sales by Dosage Strength
6.3 APAC Roflumilast Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Roflumilast by Country
7.1.1 Europe Roflumilast Sales by Country (2017-2022)
7.1.2 Europe Roflumilast Revenue by Country (2017-2022)
7.2 Europe Roflumilast Sales by Dosage Strength
7.3 Europe Roflumilast Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Roflumilast by Country
8.1.1 Middle East & Africa Roflumilast Sales by Country (2017-2022)
8.1.2 Middle East & Africa Roflumilast Revenue by Country (2017-2022)
8.2 Middle East & Africa Roflumilast Sales by Dosage Strength
8.3 Middle East & Africa Roflumilast Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Roflumilast
10.3 Manufacturing Process Analysis of Roflumilast
10.4 Industry Chain Structure of Roflumilast
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Roflumilast Distributors
11.3 Roflumilast Customer
12 WORLD FORECAST REVIEW FOR ROFLUMILAST BY GEOGRAPHIC REGION
12.1 Global Roflumilast Market Size Forecast by Region
12.1.1 Global Roflumilast Forecast by Region (2023-2028)
12.1.2 Global Roflumilast Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Roflumilast Forecast by Dosage Strength
12.7 Global Roflumilast Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Alkem Laboratories
13.1.1 Alkem Laboratories Company Information
13.1.2 Alkem Laboratories Roflumilast Product Offered
13.1.3 Alkem Laboratories Roflumilast Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Alkem Laboratories Main Business Overview
13.1.5 Alkem Laboratories Latest Developments
13.2 Astra Zeneca
13.2.1 Astra Zeneca Company Information
13.2.2 Astra Zeneca Roflumilast Product Offered
13.2.3 Astra Zeneca Roflumilast Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Astra Zeneca Main Business Overview
13.2.5 Astra Zeneca Latest Developments
13.3 Beltapharm Spa
13.3.1 Beltapharm Spa Company Information
13.3.2 Beltapharm Spa Roflumilast Product Offered
13.3.3 Beltapharm Spa Roflumilast Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Beltapharm Spa Main Business Overview
13.3.5 Beltapharm Spa Latest Developments
13.4 Breckenridge Pharma
13.4.1 Breckenridge Pharma Company Information
13.4.2 Breckenridge Pharma Roflumilast Product Offered
13.4.3 Breckenridge Pharma Roflumilast Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Breckenridge Pharma Main Business Overview
13.4.5 Breckenridge Pharma Latest Developments
13.5 Hetero Drugs
13.5.1 Hetero Drugs Company Information
13.5.2 Hetero Drugs Roflumilast Product Offered
13.5.3 Hetero Drugs Roflumilast Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Hetero Drugs Main Business Overview
13.5.5 Hetero Drugs Latest Developments
13.6 KMS Health Center
13.6.1 KMS Health Center Company Information
13.6.2 KMS Health Center Roflumilast Product Offered
13.6.3 KMS Health Center Roflumilast Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 KMS Health Center Main Business Overview
13.6.5 KMS Health Center Latest Developments
13.7 Micro Labs
13.7.1 Micro Labs Company Information
13.7.2 Micro Labs Roflumilast Product Offered
13.7.3 Micro Labs Roflumilast Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Micro Labs Main Business Overview
13.7.5 Micro Labs Latest Developments
13.8 MS Pharma
13.8.1 MS Pharma Company Information
13.8.2 MS Pharma Roflumilast Product Offered
13.8.3 MS Pharma Roflumilast Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 MS Pharma Main Business Overview
13.8.5 MS Pharma Latest Developments
13.9 MSN Laboratories
13.9.1 MSN Laboratories Company Information
13.9.2 MSN Laboratories Roflumilast Product Offered
13.9.3 MSN Laboratories Roflumilast Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 MSN Laboratories Main Business Overview
13.9.5 MSN Laboratories Latest Developments
13.10 Viatris
13.10.1 Viatris Company Information
13.10.2 Viatris Roflumilast Product Offered
13.10.3 Viatris Roflumilast Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Viatris Main Business Overview
13.10.5 Viatris Latest Developments
13.11 Orchid Pharma
13.11.1 Orchid Pharma Company Information
13.11.2 Orchid Pharma Roflumilast Product Offered
13.11.3 Orchid Pharma Roflumilast Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Orchid Pharma Main Business Overview
13.11.5 Orchid Pharma Latest Developments
13.12 Orifarm Group
13.12.1 Orifarm Group Company Information
13.12.2 Orifarm Group Roflumilast Product Offered
13.12.3 Orifarm Group Roflumilast Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Orifarm Group Main Business Overview
13.12.5 Orifarm Group Latest Developments
13.13 Precise Group
13.13.1 Precise Group Company Information
13.13.2 Precise Group Roflumilast Product Offered
13.13.3 Precise Group Roflumilast Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Precise Group Main Business Overview
13.13.5 Precise Group Latest Developments
13.14 Takeda Pharmaceutical
13.14.1 Takeda Pharmaceutical Company Information
13.14.2 Takeda Pharmaceutical Roflumilast Product Offered
13.14.3 Takeda Pharmaceutical Roflumilast Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Takeda Pharmaceutical Main Business Overview
13.14.5 Takeda Pharmaceutical Latest Developments
13.15 Torrent Group
13.15.1 Torrent Group Company Information
13.15.2 Torrent Group Roflumilast Product Offered
13.15.3 Torrent Group Roflumilast Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Torrent Group Main Business Overview
13.15.5 Torrent Group Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Roflumilast Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Roflumilast Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 250Mcg
Table 4. Major Players of 500Mcg
Table 5. Global Roflumilast Sales by Dosage Strength (2017-2022) & (Box)
Table 6. Global Roflumilast Sales Market Share by Dosage Strength (2017-2022)
Table 7. Global Roflumilast Revenue by Dosage Strength (2017-2022) & ($ million)
Table 8. Global Roflumilast Revenue Market Share by Dosage Strength (2017-2022)
Table 9. Global Roflumilast Sale Price by Dosage Strength (2017-2022) & (US$/Box)
Table 10. Global Roflumilast Sales by Application (2017-2022) & (Box)
Table 11. Global Roflumilast Sales Market Share by Application (2017-2022)
Table 12. Global Roflumilast Revenue by Application (2017-2022)
Table 13. Global Roflumilast Revenue Market Share by Application (2017-2022)
Table 14. Global Roflumilast Sale Price by Application (2017-2022) & (US$/Box)
Table 15. Global Roflumilast Sales by Company (2020-2022) & (Box)
Table 16. Global Roflumilast Sales Market Share by Company (2020-2022)
Table 17. Global Roflumilast Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Roflumilast Revenue Market Share by Company (2020-2022)
Table 19. Global Roflumilast Sale Price by Company (2020-2022) & (US$/Box)
Table 20. Key Manufacturers Roflumilast Producing Area Distribution and Sales Area
Table 21. Players Roflumilast Products Offered
Table 22. Roflumilast Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Roflumilast Sales by Geographic Region (2017-2022) & (Box)
Table 26. Global Roflumilast Sales Market Share Geographic Region (2017-2022)
Table 27. Global Roflumilast Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Roflumilast Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Roflumilast Sales by Country/Region (2017-2022) & (Box)
Table 30. Global Roflumilast Sales Market Share by Country/Region (2017-2022)
Table 31. Global Roflumilast Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Roflumilast Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Roflumilast Sales by Country (2017-2022) & (Box)
Table 34. Americas Roflumilast Sales Market Share by Country (2017-2022)
Table 35. Americas Roflumilast Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Roflumilast Revenue Market Share by Country (2017-2022)
Table 37. Americas Roflumilast Sales by Type (2017-2022) & (Box)
Table 38. Americas Roflumilast Sales Market Share by Dosage Strength (2017-2022)
Table 39. Americas Roflumilast Sales by Application (2017-2022) & (Box)
Table 40. Americas Roflumilast Sales Market Share by Application (2017-2022)
Table 41. APAC Roflumilast Sales by Region (2017-2022) & (Box)
Table 42. APAC Roflumilast Sales Market Share by Region (2017-2022)
Table 43. APAC Roflumilast Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Roflumilast Revenue Market Share by Region (2017-2022)
Table 45. APAC Roflumilast Sales by Dosage Strength (2017-2022) & (Box)
Table 46. APAC Roflumilast Sales Market Share by Dosage Strength (2017-2022)
Table 47. APAC Roflumilast Sales by Application (2017-2022) & (Box)
Table 48. APAC Roflumilast Sales Market Share by Application (2017-2022)
Table 49. Europe Roflumilast Sales by Country (2017-2022) & (Box)
Table 50. Europe Roflumilast Sales Market Share by Country (2017-2022)
Table 51. Europe Roflumilast Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Roflumilast Revenue Market Share by Country (2017-2022)
Table 53. Europe Roflumilast Sales by Type (2017-2022) & (Box)
Table 54. Europe Roflumilast Sales Market Share by Dosage Strength (2017-2022)
Table 55. Europe Roflumilast Sales by Application (2017-2022) & (Box)
Table 56. Europe Roflumilast Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Roflumilast Sales by Country (2017-2022) & (Box)
Table 58. Middle East & Africa Roflumilast Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Roflumilast Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Roflumilast Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Roflumilast Sales by Dosage Strength (2017-2022) & (Box)
Table 62. Middle East & Africa Roflumilast Sales Market Share by Dosage Strength (2017-2022)
Table 63. Middle East & Africa Roflumilast Sales by Application (2017-2022) & (Box)
Table 64. Middle East & Africa Roflumilast Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Roflumilast
Table 66. Key Market Challenges & Risks of Roflumilast
Table 67. Key Industry Trends of Roflumilast
Table 68. Roflumilast Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Roflumilast Distributors List
Table 71. Roflumilast Customer List
Table 72. Global Roflumilast Sales Forecast by Region (2023-2028) & (Box)
Table 73. Global Roflumilast Sales Market Forecast by Region
Table 74. Global Roflumilast Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Roflumilast Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Roflumilast Sales Forecast by Country (2023-2028) & (Box)
Table 77. Americas Roflumilast Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Roflumilast Sales Forecast by Region (2023-2028) & (Box)
Table 79. APAC Roflumilast Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Roflumilast Sales Forecast by Country (2023-2028) & (Box)
Table 81. Europe Roflumilast Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Roflumilast Sales Forecast by Country (2023-2028) & (Box)
Table 83. Middle East & Africa Roflumilast Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Roflumilast Sales Forecast by Dosage Strength (2023-2028) & (Box)
Table 85. Global Roflumilast Sales Market Share Forecast by Dosage Strength (2023-2028)
Table 86. Global Roflumilast Revenue Forecast by Dosage Strength (2023-2028) & ($ Millions)
Table 87. Global Roflumilast Revenue Market Share Forecast by Dosage Strength (2023-2028)
Table 88. Global Roflumilast Sales Forecast by Application (2023-2028) & (Box)
Table 89. Global Roflumilast Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Roflumilast Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Roflumilast Revenue Market Share Forecast by Application (2023-2028)
Table 92. Alkem Laboratories Basic Information, Roflumilast Manufacturing Base, Sales Area and Its Competitors
Table 93. Alkem Laboratories Roflumilast Product Offered
Table 94. Alkem Laboratories Roflumilast Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 95. Alkem Laboratories Main Business
Table 96. Alkem Laboratories Latest Developments
Table 97. Astra Zeneca Basic Information, Roflumilast Manufacturing Base, Sales Area and Its Competitors
Table 98. Astra Zeneca Roflumilast Product Offered
Table 99. Astra Zeneca Roflumilast Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 100. Astra Zeneca Main Business
Table 101. Astra Zeneca Latest Developments
Table 102. Beltapharm Spa Basic Information, Roflumilast Manufacturing Base, Sales Area and Its Competitors
Table 103. Beltapharm Spa Roflumilast Product Offered
Table 104. Beltapharm Spa Roflumilast Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 105. Beltapharm Spa Main Business
Table 106. Beltapharm Spa Latest Developments
Table 107. Breckenridge Pharma Basic Information, Roflumilast Manufacturing Base, Sales Area and Its Competitors
Table 108. Breckenridge Pharma Roflumilast Product Offered
Table 109. Breckenridge Pharma Roflumilast Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 110. Breckenridge Pharma Main Business
Table 111. Breckenridge Pharma Latest Developments
Table 112. Hetero Drugs Basic Information, Roflumilast Manufacturing Base, Sales Area and Its Competitors
Table 113. Hetero Drugs Roflumilast Product Offered
Table 114. Hetero Drugs Roflumilast Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 115. Hetero Drugs Main Business
Table 116. Hetero Drugs Latest Developments
Table 117. KMS Health Center Basic Information, Roflumilast Manufacturing Base, Sales Area and Its Competitors
Table 118. KMS Health Center Roflumilast Product Offered
Table 119. KMS Health Center Roflumilast Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 120. KMS Health Center Main Business
Table 121. KMS Health Center Latest Developments
Table 122. Micro Labs Basic Information, Roflumilast Manufacturing Base, Sales Area and Its Competitors
Table 123. Micro Labs Roflumilast Product Offered
Table 124. Micro Labs Roflumilast Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 125. Micro Labs Main Business
Table 126. Micro Labs Latest Developments
Table 127. MS Pharma Basic Information, Roflumilast Manufacturing Base, Sales Area and Its Competitors
Table 128. MS Pharma Roflumilast Product Offered
Table 129. MS Pharma Roflumilast Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 130. MS Pharma Main Business
Table 131. MS Pharma Latest Developments
Table 132. MSN Laboratories Basic Information, Roflumilast Manufacturing Base, Sales Area and Its Competitors
Table 133. MSN Laboratories Roflumilast Product Offered
Table 134. MSN Laboratories Roflumilast Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 135. MSN Laboratories Main Business
Table 136. MSN Laboratories Latest Developments
Table 137. Viatris Basic Information, Roflumilast Manufacturing Base, Sales Area and Its Competitors
Table 138. Viatris Roflumilast Product Offered
Table 139. Viatris Roflumilast Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 140. Viatris Main Business
Table 141. Viatris Latest Developments
Table 142. Orchid Pharma Basic Information, Roflumilast Manufacturing Base, Sales Area and Its Competitors
Table 143. Orchid Pharma Roflumilast Product Offered
Table 144. Orchid Pharma Roflumilast Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 145. Orchid Pharma Main Business
Table 146. Orchid Pharma Latest Developments
Table 147. Orifarm Group Basic Information, Roflumilast Manufacturing Base, Sales Area and Its Competitors
Table 148. Orifarm Group Roflumilast Product Offered
Table 149. Orifarm Group Roflumilast Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 150. Orifarm Group Main Business
Table 151. Orifarm Group Latest Developments
Table 152. Precise Group Basic Information, Roflumilast Manufacturing Base, Sales Area and Its Competitors
Table 153. Precise Group Roflumilast Product Offered
Table 154. Precise Group Roflumilast Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 155. Precise Group Main Business
Table 156. Precise Group Latest Developments
Table 157. Takeda Pharmaceutical Basic Information, Roflumilast Manufacturing Base, Sales Area and Its Competitors
Table 158. Takeda Pharmaceutical Roflumilast Product Offered
Table 159. Takeda Pharmaceutical Roflumilast Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 160. Takeda Pharmaceutical Main Business
Table 161. Takeda Pharmaceutical Latest Developments
Table 162. Torrent Group Basic Information, Roflumilast Manufacturing Base, Sales Area and Its Competitors
Table 163. Torrent Group Roflumilast Product Offered
Table 164. Torrent Group Roflumilast Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 165. Torrent Group Main Business
Table 166. Torrent Group Latest Developments
Table 1. Roflumilast Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Roflumilast Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 250Mcg
Table 4. Major Players of 500Mcg
Table 5. Global Roflumilast Sales by Dosage Strength (2017-2022) & (Box)
Table 6. Global Roflumilast Sales Market Share by Dosage Strength (2017-2022)
Table 7. Global Roflumilast Revenue by Dosage Strength (2017-2022) & ($ million)
Table 8. Global Roflumilast Revenue Market Share by Dosage Strength (2017-2022)
Table 9. Global Roflumilast Sale Price by Dosage Strength (2017-2022) & (US$/Box)
Table 10. Global Roflumilast Sales by Application (2017-2022) & (Box)
Table 11. Global Roflumilast Sales Market Share by Application (2017-2022)
Table 12. Global Roflumilast Revenue by Application (2017-2022)
Table 13. Global Roflumilast Revenue Market Share by Application (2017-2022)
Table 14. Global Roflumilast Sale Price by Application (2017-2022) & (US$/Box)
Table 15. Global Roflumilast Sales by Company (2020-2022) & (Box)
Table 16. Global Roflumilast Sales Market Share by Company (2020-2022)
Table 17. Global Roflumilast Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Roflumilast Revenue Market Share by Company (2020-2022)
Table 19. Global Roflumilast Sale Price by Company (2020-2022) & (US$/Box)
Table 20. Key Manufacturers Roflumilast Producing Area Distribution and Sales Area
Table 21. Players Roflumilast Products Offered
Table 22. Roflumilast Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Roflumilast Sales by Geographic Region (2017-2022) & (Box)
Table 26. Global Roflumilast Sales Market Share Geographic Region (2017-2022)
Table 27. Global Roflumilast Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Roflumilast Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Roflumilast Sales by Country/Region (2017-2022) & (Box)
Table 30. Global Roflumilast Sales Market Share by Country/Region (2017-2022)
Table 31. Global Roflumilast Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Roflumilast Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Roflumilast Sales by Country (2017-2022) & (Box)
Table 34. Americas Roflumilast Sales Market Share by Country (2017-2022)
Table 35. Americas Roflumilast Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Roflumilast Revenue Market Share by Country (2017-2022)
Table 37. Americas Roflumilast Sales by Type (2017-2022) & (Box)
Table 38. Americas Roflumilast Sales Market Share by Dosage Strength (2017-2022)
Table 39. Americas Roflumilast Sales by Application (2017-2022) & (Box)
Table 40. Americas Roflumilast Sales Market Share by Application (2017-2022)
Table 41. APAC Roflumilast Sales by Region (2017-2022) & (Box)
Table 42. APAC Roflumilast Sales Market Share by Region (2017-2022)
Table 43. APAC Roflumilast Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Roflumilast Revenue Market Share by Region (2017-2022)
Table 45. APAC Roflumilast Sales by Dosage Strength (2017-2022) & (Box)
Table 46. APAC Roflumilast Sales Market Share by Dosage Strength (2017-2022)
Table 47. APAC Roflumilast Sales by Application (2017-2022) & (Box)
Table 48. APAC Roflumilast Sales Market Share by Application (2017-2022)
Table 49. Europe Roflumilast Sales by Country (2017-2022) & (Box)
Table 50. Europe Roflumilast Sales Market Share by Country (2017-2022)
Table 51. Europe Roflumilast Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Roflumilast Revenue Market Share by Country (2017-2022)
Table 53. Europe Roflumilast Sales by Type (2017-2022) & (Box)
Table 54. Europe Roflumilast Sales Market Share by Dosage Strength (2017-2022)
Table 55. Europe Roflumilast Sales by Application (2017-2022) & (Box)
Table 56. Europe Roflumilast Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Roflumilast Sales by Country (2017-2022) & (Box)
Table 58. Middle East & Africa Roflumilast Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Roflumilast Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Roflumilast Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Roflumilast Sales by Dosage Strength (2017-2022) & (Box)
Table 62. Middle East & Africa Roflumilast Sales Market Share by Dosage Strength (2017-2022)
Table 63. Middle East & Africa Roflumilast Sales by Application (2017-2022) & (Box)
Table 64. Middle East & Africa Roflumilast Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Roflumilast
Table 66. Key Market Challenges & Risks of Roflumilast
Table 67. Key Industry Trends of Roflumilast
Table 68. Roflumilast Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Roflumilast Distributors List
Table 71. Roflumilast Customer List
Table 72. Global Roflumilast Sales Forecast by Region (2023-2028) & (Box)
Table 73. Global Roflumilast Sales Market Forecast by Region
Table 74. Global Roflumilast Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Roflumilast Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Roflumilast Sales Forecast by Country (2023-2028) & (Box)
Table 77. Americas Roflumilast Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Roflumilast Sales Forecast by Region (2023-2028) & (Box)
Table 79. APAC Roflumilast Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Roflumilast Sales Forecast by Country (2023-2028) & (Box)
Table 81. Europe Roflumilast Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Roflumilast Sales Forecast by Country (2023-2028) & (Box)
Table 83. Middle East & Africa Roflumilast Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Roflumilast Sales Forecast by Dosage Strength (2023-2028) & (Box)
Table 85. Global Roflumilast Sales Market Share Forecast by Dosage Strength (2023-2028)
Table 86. Global Roflumilast Revenue Forecast by Dosage Strength (2023-2028) & ($ Millions)
Table 87. Global Roflumilast Revenue Market Share Forecast by Dosage Strength (2023-2028)
Table 88. Global Roflumilast Sales Forecast by Application (2023-2028) & (Box)
Table 89. Global Roflumilast Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Roflumilast Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Roflumilast Revenue Market Share Forecast by Application (2023-2028)
Table 92. Alkem Laboratories Basic Information, Roflumilast Manufacturing Base, Sales Area and Its Competitors
Table 93. Alkem Laboratories Roflumilast Product Offered
Table 94. Alkem Laboratories Roflumilast Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 95. Alkem Laboratories Main Business
Table 96. Alkem Laboratories Latest Developments
Table 97. Astra Zeneca Basic Information, Roflumilast Manufacturing Base, Sales Area and Its Competitors
Table 98. Astra Zeneca Roflumilast Product Offered
Table 99. Astra Zeneca Roflumilast Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 100. Astra Zeneca Main Business
Table 101. Astra Zeneca Latest Developments
Table 102. Beltapharm Spa Basic Information, Roflumilast Manufacturing Base, Sales Area and Its Competitors
Table 103. Beltapharm Spa Roflumilast Product Offered
Table 104. Beltapharm Spa Roflumilast Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 105. Beltapharm Spa Main Business
Table 106. Beltapharm Spa Latest Developments
Table 107. Breckenridge Pharma Basic Information, Roflumilast Manufacturing Base, Sales Area and Its Competitors
Table 108. Breckenridge Pharma Roflumilast Product Offered
Table 109. Breckenridge Pharma Roflumilast Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 110. Breckenridge Pharma Main Business
Table 111. Breckenridge Pharma Latest Developments
Table 112. Hetero Drugs Basic Information, Roflumilast Manufacturing Base, Sales Area and Its Competitors
Table 113. Hetero Drugs Roflumilast Product Offered
Table 114. Hetero Drugs Roflumilast Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 115. Hetero Drugs Main Business
Table 116. Hetero Drugs Latest Developments
Table 117. KMS Health Center Basic Information, Roflumilast Manufacturing Base, Sales Area and Its Competitors
Table 118. KMS Health Center Roflumilast Product Offered
Table 119. KMS Health Center Roflumilast Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 120. KMS Health Center Main Business
Table 121. KMS Health Center Latest Developments
Table 122. Micro Labs Basic Information, Roflumilast Manufacturing Base, Sales Area and Its Competitors
Table 123. Micro Labs Roflumilast Product Offered
Table 124. Micro Labs Roflumilast Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 125. Micro Labs Main Business
Table 126. Micro Labs Latest Developments
Table 127. MS Pharma Basic Information, Roflumilast Manufacturing Base, Sales Area and Its Competitors
Table 128. MS Pharma Roflumilast Product Offered
Table 129. MS Pharma Roflumilast Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 130. MS Pharma Main Business
Table 131. MS Pharma Latest Developments
Table 132. MSN Laboratories Basic Information, Roflumilast Manufacturing Base, Sales Area and Its Competitors
Table 133. MSN Laboratories Roflumilast Product Offered
Table 134. MSN Laboratories Roflumilast Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 135. MSN Laboratories Main Business
Table 136. MSN Laboratories Latest Developments
Table 137. Viatris Basic Information, Roflumilast Manufacturing Base, Sales Area and Its Competitors
Table 138. Viatris Roflumilast Product Offered
Table 139. Viatris Roflumilast Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 140. Viatris Main Business
Table 141. Viatris Latest Developments
Table 142. Orchid Pharma Basic Information, Roflumilast Manufacturing Base, Sales Area and Its Competitors
Table 143. Orchid Pharma Roflumilast Product Offered
Table 144. Orchid Pharma Roflumilast Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 145. Orchid Pharma Main Business
Table 146. Orchid Pharma Latest Developments
Table 147. Orifarm Group Basic Information, Roflumilast Manufacturing Base, Sales Area and Its Competitors
Table 148. Orifarm Group Roflumilast Product Offered
Table 149. Orifarm Group Roflumilast Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 150. Orifarm Group Main Business
Table 151. Orifarm Group Latest Developments
Table 152. Precise Group Basic Information, Roflumilast Manufacturing Base, Sales Area and Its Competitors
Table 153. Precise Group Roflumilast Product Offered
Table 154. Precise Group Roflumilast Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 155. Precise Group Main Business
Table 156. Precise Group Latest Developments
Table 157. Takeda Pharmaceutical Basic Information, Roflumilast Manufacturing Base, Sales Area and Its Competitors
Table 158. Takeda Pharmaceutical Roflumilast Product Offered
Table 159. Takeda Pharmaceutical Roflumilast Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 160. Takeda Pharmaceutical Main Business
Table 161. Takeda Pharmaceutical Latest Developments
Table 162. Torrent Group Basic Information, Roflumilast Manufacturing Base, Sales Area and Its Competitors
Table 163. Torrent Group Roflumilast Product Offered
Table 164. Torrent Group Roflumilast Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 165. Torrent Group Main Business
Table 166. Torrent Group Latest Developments
LIST OF FIGURES
Figure 1. Picture of Roflumilast
Figure 2. Roflumilast Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Roflumilast Sales Growth Rate 2017-2028 (Box)
Figure 7. Global Roflumilast Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Roflumilast Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 250Mcg
Figure 10. Product Picture of 500Mcg
Figure 11. Global Roflumilast Sales Market Share by Dosage Strength in 2021
Figure 12. Global Roflumilast Revenue Market Share by Dosage Strength (2017-2022)
Figure 13. Roflumilast Consumed in Hospital
Figure 14. Global Roflumilast Market: Hospital (2017-2022) & (Box)
Figure 15. Roflumilast Consumed in Clinic
Figure 16. Global Roflumilast Market: Clinic (2017-2022) & (Box)
Figure 17. Roflumilast Consumed in Other
Figure 18. Global Roflumilast Market: Other (2017-2022) & (Box)
Figure 19. Global Roflumilast Sales Market Share by Application (2017-2022)
Figure 20. Global Roflumilast Revenue Market Share by Application in 2021
Figure 21. Roflumilast Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Roflumilast Revenue Market Share by Company in 2021
Figure 23. Global Roflumilast Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Roflumilast Revenue Market Share by Geographic Region in 2021
Figure 25. Global Roflumilast Sales Market Share by Region (2017-2022)
Figure 26. Global Roflumilast Revenue Market Share by Country/Region in 2021
Figure 27. Americas Roflumilast Sales 2017-2022 (Box)
Figure 28. Americas Roflumilast Revenue 2017-2022 ($ Millions)
Figure 29. APAC Roflumilast Sales 2017-2022 (Box)
Figure 30. APAC Roflumilast Revenue 2017-2022 ($ Millions)
Figure 31. Europe Roflumilast Sales 2017-2022 (Box)
Figure 32. Europe Roflumilast Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Roflumilast Sales 2017-2022 (Box)
Figure 34. Middle East & Africa Roflumilast Revenue 2017-2022 ($ Millions)
Figure 35. Americas Roflumilast Sales Market Share by Country in 2021
Figure 36. Americas Roflumilast Revenue Market Share by Country in 2021
Figure 37. United States Roflumilast Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Roflumilast Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Roflumilast Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Roflumilast Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Roflumilast Sales Market Share by Region in 2021
Figure 42. APAC Roflumilast Revenue Market Share by Regions in 2021
Figure 43. China Roflumilast Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Roflumilast Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Roflumilast Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Roflumilast Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Roflumilast Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Roflumilast Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Roflumilast Sales Market Share by Country in 2021
Figure 50. Europe Roflumilast Revenue Market Share by Country in 2021
Figure 51. Germany Roflumilast Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Roflumilast Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Roflumilast Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Roflumilast Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Roflumilast Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Roflumilast Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Roflumilast Revenue Market Share by Country in 2021
Figure 58. Egypt Roflumilast Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Roflumilast Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Roflumilast Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Roflumilast Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Roflumilast Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Roflumilast in 2021
Figure 64. Manufacturing Process Analysis of Roflumilast
Figure 65. Industry Chain Structure of Roflumilast
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Figure 1. Picture of Roflumilast
Figure 2. Roflumilast Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Roflumilast Sales Growth Rate 2017-2028 (Box)
Figure 7. Global Roflumilast Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Roflumilast Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 250Mcg
Figure 10. Product Picture of 500Mcg
Figure 11. Global Roflumilast Sales Market Share by Dosage Strength in 2021
Figure 12. Global Roflumilast Revenue Market Share by Dosage Strength (2017-2022)
Figure 13. Roflumilast Consumed in Hospital
Figure 14. Global Roflumilast Market: Hospital (2017-2022) & (Box)
Figure 15. Roflumilast Consumed in Clinic
Figure 16. Global Roflumilast Market: Clinic (2017-2022) & (Box)
Figure 17. Roflumilast Consumed in Other
Figure 18. Global Roflumilast Market: Other (2017-2022) & (Box)
Figure 19. Global Roflumilast Sales Market Share by Application (2017-2022)
Figure 20. Global Roflumilast Revenue Market Share by Application in 2021
Figure 21. Roflumilast Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Roflumilast Revenue Market Share by Company in 2021
Figure 23. Global Roflumilast Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Roflumilast Revenue Market Share by Geographic Region in 2021
Figure 25. Global Roflumilast Sales Market Share by Region (2017-2022)
Figure 26. Global Roflumilast Revenue Market Share by Country/Region in 2021
Figure 27. Americas Roflumilast Sales 2017-2022 (Box)
Figure 28. Americas Roflumilast Revenue 2017-2022 ($ Millions)
Figure 29. APAC Roflumilast Sales 2017-2022 (Box)
Figure 30. APAC Roflumilast Revenue 2017-2022 ($ Millions)
Figure 31. Europe Roflumilast Sales 2017-2022 (Box)
Figure 32. Europe Roflumilast Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Roflumilast Sales 2017-2022 (Box)
Figure 34. Middle East & Africa Roflumilast Revenue 2017-2022 ($ Millions)
Figure 35. Americas Roflumilast Sales Market Share by Country in 2021
Figure 36. Americas Roflumilast Revenue Market Share by Country in 2021
Figure 37. United States Roflumilast Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Roflumilast Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Roflumilast Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Roflumilast Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Roflumilast Sales Market Share by Region in 2021
Figure 42. APAC Roflumilast Revenue Market Share by Regions in 2021
Figure 43. China Roflumilast Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Roflumilast Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Roflumilast Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Roflumilast Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Roflumilast Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Roflumilast Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Roflumilast Sales Market Share by Country in 2021
Figure 50. Europe Roflumilast Revenue Market Share by Country in 2021
Figure 51. Germany Roflumilast Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Roflumilast Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Roflumilast Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Roflumilast Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Roflumilast Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Roflumilast Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Roflumilast Revenue Market Share by Country in 2021
Figure 58. Egypt Roflumilast Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Roflumilast Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Roflumilast Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Roflumilast Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Roflumilast Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Roflumilast in 2021
Figure 64. Manufacturing Process Analysis of Roflumilast
Figure 65. Industry Chain Structure of Roflumilast
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
